Cosmoclinic Logo +30 210 46 11 204
KISOURAS IORDANIS

KISOURAS IORDANIS

GASTROENTEROLOGIST

Professional Experience

  • Scientific Associate with the Gastroenterology Department, General Hospital “Elpis”, 2016–2017

  • Scientific Associate with the Diagnostic Center–Polyclinic “Iatrokosmos”, 2016–2017

  • Private Medical Practice, 2016 – present

  • Scientific Associate, Endoscopy Department, Day Care Unit based in Piraeus, 2017

  • Scientific Associate, Endoscopy Department, “Bioclinic Piraeus”, 2017–2019

  • Scientific Associate, Endoscopy Department, Diagnostic Center “Hippokratis”, 2018–2019

  • Scientific Associate, Gastroenterology Department, “Rea” Clinic, 2019 – present

  • Scientific Associate, Endoscopy Department, “Cosmoclinic”, 2025 – present

Education

  • Medical School, University of Verona, Italy – Grade: Excellent (95/110), 2004

  • Rural Medical Service at the Regional Clinic of Oinoi, Health Center of Argos Orestiko–Kastoria, 2006–2007

  • Resident in Internal Medicine, 2nd Department of Internal Medicine, General Hospital of Drama, 2008–2009

  • Resident in Gastroenterology, Gastroenterology Department, General Hospital “Alexandra”, 2012–2016

Specialty

Gastroenterology, General Hospital “Alexandra”, 2016

Foreign Languages

  • Italian

  • English

Publications

  • Zampeli E., Anapliotis P., Xourafas V., Kissouras I., Mavros M., Kalantzis G., Gkagaris G., Kalampoki V., Michopoulos S. Replacing tetracycline with amoxicillin in the second eradication regimen ensures comparable effectiveness, Oral presentation, 32nd Panhellenic Congress of Gastroenterology, Athens, November 29 – December 1, 2012

  • Chouzouri V., Zampeli E., Manios E., Anapliotis P., Xourafas V., Kissouras I., Kalantzis G., Kalampoki V., Zakopoulos N., Michopoulos S. Non-alcoholic fatty liver disease (NAFLD) is not more common in hypertensive patients or in non-dippers compared to normotensive individuals. Award-winning poster presentation, 32nd Panhellenic Congress of Gastroenterology, Athens, November 29 – December 1, 2012

  • Zampeli E., Argyriou K., Xourafas V., Kourkoutas H., Kissouras I., Psychogiou V., Polymeneas G., Michopoulos S. Acute Hepatitis B with concomitant acute pancreatitis. Poster presentation, 13th Panhellenic Hepatology Congress, Rhodes, May 9–12, 2013

  • Xourafas V., Kissouras I., Kourkoutas H., Argyriou K., Matsouka H., Barbarousi D., Zampeli E., MichopoulosAplastic anemia from combination therapy with pegylated interferon (Peg-INF) and ribavirin (RIBA) in a patient with HCV infection. Poster presentation, 13th Panhellenic Hepatology Congress, Rhodes, May 9–12, 2013

  • Michopoulos S., Zampeli E., Argyriou K., Xourafas V., Kourkoutas H., Kissouras I., Kalantzis G., Martinez-Gonzalez B., Sgouras D., Mentis A. Increased clarithromycin resistance rates did not affect the effectiveness of first-line treatment for Helicobacter pylori over the past six years. Annals of Gastroenterology, 2013;26(Suppl):26

  • Michopoulos S., Zampeli E., Argyriou K., Xourafas V., Kourkoutas H., Kissouras I., Kalatzis G., Martinez-Gonzalez B., Sgouras D., Mentis A. Standard triple regimen eradication rates for Helicobacter pylori are closely related to clarithromycin resistance levels. Abstract, Digestive Disease Week, Chicago, Illinois, May 3–6, 2014

  • Michopoulos S., Zampeli E., Argyriou K., Xourafas V., Kisouras I., Kourkoutas H., Martinez-Gonzalez B., Sgouras D., Mentis A. Second-line levofloxacin-based triple therapies provide similar Helicobacter pylori eradication rates to bismuth-based quadruple therapies. Abstract, 22nd United European Gastroenterology Week, Vienna, October 18–22, 2014

  • Michopoulos S., Argyriou K., Kourkoutas H., Kissouras I., Leonidakis G., Zampeli E., Martinez-Gonzalez B., Sgouras D., Mentis A. Second-line triple regimens with levofloxacin achieve similar Helicobacter pylori eradication rates to bismuth-containing regimens. Oral presentation, 34th Panhellenic Congress of Gastroenterology, Athens, December 4–6, 2014

  • Michopoulos S., Kourkoutas H., Argyriou K., Kissouras I., Leonidakis G., Zampeli E., Stamatelopoulos K., Dimopoulos A.M. Colorectal cancer screening has lower participation compared with other preventive screenings even among well-informed populations. Oral presentation, 34th Panhellenic Congress of Gastroenterology, Athens, December 4–6, 2014

    Michopoulos S., Argyriou K., Kourkoutas H., Kissouras I., Leonidakis G., Xourafas V., Zampeli E., Sotiropoulou N., Petraki K., Martinez-Gonzalez B., Sgouras D., Mentis A.M. Helicobacter pylori eradication with the non-bismuth quadruple regimen does not differ between patients with and without ulcer. Poster presentation, 35th Panhellenic Congress of Gastroenterology, Kalamata, October 8–11, 2015